Edwards Lifesciences shares got a boost on fourth-quarter results that came in ahead of the consensus forecast. Shares of EW were up more than 6% to $75.68 apiece by midday trading today, the day after the after-hours earnings report. The Irvine, California–based medtech company reported profits of $385.6 million. That equals 65¢ per share on […]
MassDevice Earnings Roundup
Inspire Medical faces DOJ investigation
Inspire Medical Systems shares dipped — but have since mostly recovered — following news of a government investigation following fourth-quarter results. As of midday today, INSP shares were up more than 2% to $185 apiece. (They were down more than 5% over the past five days.) The company disclosed yesterday evening that on Jan. 17, […]
Zimmer Biomet beats The Street in Q4
Zimmer Biomet shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus forecast on Wall Street. Shares of ZBH fell 1.6% to $106.50 apiece in pre-market trading today. The Warsaw, Indiana-based orthopedic device company reported profits of $239.4 million. That equals $1.20 per share on sales of $2.023 billion for […]
BD announces intent to sell Life Sciences business, beats Street in Q1
BD announced that its board unanimously authorized management to pursue the separation of its Life Sciences business. Shares of BDX fell 1.3% to $241.85 apiece in pre-market trading today. The company plans to separate its Biosciences and Diagnostic Solutions unit from the rest of BD. It hopes to enhance strategic focus and growth-oriented investments and […]
CVRx stock dips on Q4 EPS miss
CVRx (Nasdaq:CVRX) shares took a hit today on fourth-quarter results that fell short of earnings per share expectations. Shares of CVRX fell 10% to $14.63 apiece in mid-morning trading today. The Minneapolis-based maker of neuromodulation devices for treating heart failure reported losses of $10.65 million. That equals 43¢ per share on sales of $15.34 million […]
Boston Scientific expects double-digit sales growth in 2025 following Street-beating Q4
Boston Scientific shares were up this morning on fourth-quarter results that beat the consensus forecast on Wall Street. Shares of BSX rose more than 2% to $105.77 apiece in morning trading today. The Marlborough, Massachusetts–based medtech company reported profits of $566 million. That equals 38¢ per share on sales of $4.56 billion for the three […]
ResMed revenue up 10% in Q2 — but GLP-1 questions remain
ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 results. The results, out after market close yesterday evening, came more than a month after the FDA approved Eli Lilly’s GLP-1 drug Zepbound (tirzepatide) as the first and only prescription drug to treat sleep apnea. CMS […]
Intuitive stock slips after company warns of potential tariff impact
Intuitive stock declined about 2% in after-hours trading after the company warned new import taxes could hurt its business. The Sunnyvale, California–based surgical robotics last week released preliminary results for the fourth quarter ahead of the company’s presentation at the J.P. Morgan Healthcare Conference. Those results included a 17% growth in worldwide da Vinci procedures […]
Abbott sales come up just shy of Q4 expectations on Wall Street, highlights EP growth
Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright spot. Shares of ABT dipped 2.1% to $114.31 apiece in pre-market trading today. However, they rose 0.6% to $117.47 after the market opened. The Abbott Park, Illinois–based company reported profits of $9.2 billion for the quarter. That […]
Johnson & Johnson MedTech sales grow 6.2% in 2024, driven by EP, Abiomed
Johnson & Johnson shares dipped slightly before hours today on fourth-quarter results that topped the consensus forecast. Shares of JNJ fell more than 3% to $143.36 apiece in morning trading today. The New Brunswick, New Jersey–based medtech giant reported profits of $3.4 billion. That equals $1.41 per share on sales of $22.52 billion for the […]
Masimo expects healthcare sales to grow around 10% in 2025
Masimo today announced preliminary financial results for the fourth quarter of 2024 and for the full year. MASI shares fell 2.5% to $167.73 apiece this morning. The annual results follow a year of significant upheaval at the top of the company. Founder and CEO Joe Kiani resigned after a September shareholder vote that ousted him from the position of […]